Dean Ferrigno
Direttore Finanziario/CFO presso Arog Pharmaceuticals, Inc.
Profilo
Dean Ferrigno is currently the CFO & Principal Accounting Officer at Arog Pharmaceuticals, Inc. He previously worked as the Vice President-Global Finance at SCILEX Pharmaceuticals, Inc. from 2015 to 2016.
He also worked as the Chief Accounting Officer & VP-Finance at Sorrento Therapeutics, Inc. Additionally, he was the Vice President-Finance at Statewide Clinical Trials Network of Texas from 2011 to 2013.
Mr. Ferrigno holds an MBA degree from Fairleigh Dickinson University.
Posizioni attive di Dean Ferrigno
| Società | Posizione | Inizio |
|---|---|---|
Arog Pharmaceuticals, Inc.
 Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | Direttore Finanziario/CFO | 01/03/2018 |
Precedenti posizioni note di Dean Ferrigno
| Società | Posizione | Fine |
|---|---|---|
| SORRENTO THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 23/03/2018 |
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Direttore Finanziario/CFO | 01/11/2016 |
Statewide Clinical Trials Network of Texas
 Statewide Clinical Trials Network of Texas Miscellaneous Commercial ServicesCommercial Services Statewide Clinical Trials Network of Texas is a non-profit organization that operates as an oncology research network. | Direttore Finanziario/CFO | 01/02/2013 |
Formazione di Dean Ferrigno
| Fairleigh Dickinson University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Health Technology |
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | Health Technology |
Statewide Clinical Trials Network of Texas
Statewide Clinical Trials Network of Texas Miscellaneous Commercial ServicesCommercial Services Statewide Clinical Trials Network of Texas is a non-profit organization that operates as an oncology research network. | Commercial Services |
- Borsa valori
- Insiders
- Dean Ferrigno
